Contribution margins and utilization of transcatheter aortic valve replacement versus surgical aortic valve replacement in the Medicare population
Most hospitals had positive CMs for TAVR and nearly all had positive CMs for SAVR. Positive CMs for TAVR for individual hospitals were associated with a significant increase in the utilization of TAVR. However, the magnitude of difference in TAVR versus SAVR CM was not associated with differential procedural use.
Authors
- Jay Giri (ORCID: https://orcid.org/0000-0002-8076-0098)
- Pavan Atluri (ORCID: https://orcid.org/0000-0003-0229-085X)
- Peter W. Groeneveld (ORCID: https://orcid.org/0000-0002-7374-4292)
- Nimesh D. Desai (ORCID: https://orcid.org/0000-0002-4456-5674)
- Dharam J. Kumbhani (ORCID: https://orcid.org/0000-0003-4321-4538)
- Paul N. Fiorilli (ORCID: https://orcid.org/0000-0002-1874-5188)
- Fenton H. McCarthy (ORCID: https://orcid.org/0000-0003-2129-6739)
- Ashwin S. Nathan (ORCID: https://orcid.org/0000-0002-7227-6423)
- Sammy Elmariah (ORCID: https://orcid.org/0000-0002-8013-8733)
- Lauren A. Eberly (ORCID: https://orcid.org/0000-0003-0879-7694)
- Howard C. Herrmann (ORCID: https://orcid.org/0000-0003-3322-9568)
- Alexander C. Fanaroff (ORCID: https://orcid.org/0000-0002-9060-5307)
- Kaitlyn Shultz
- Sameed Ahmed M. Khatana (ORCID: https://orcid.org/0000-0002-1345-3004)
- Kriyana P. Reddy (ORCID: https://orcid.org/0000-0002-5569-6450)
- David Jonathan Cohen (ORCID: https://orcid.org/0000-0001-9163-724X)
- Wilson Y. Szeto
Institutions
- Providence Sacred Heart Medical Center (US)
- St. Francis Hospital (US)
- Penn Center for AIDS Research (US)
- Philadelphia VA Medical Center (US)
- Cardiovascular Research Foundation (US)
- University of Pennsylvania (US)
- The University of Texas Southwestern Medical Center (US)
Publication Details
- Journal
- American Heart Journal
- Published
- 2024-11-27
- DOI
- https://doi.org/10.1016/j.ahj.2024.11.010
- Citations
- 2
- Primary Topic
- Cardiac Valve Diseases and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.80
Funders
- Edwards Lifesciences